N. Maheswari

Cilostazol or clopidogrel? Comparative evidence on bleeding risk, stroke recurrence, and mortality in ischemic stroke – A systematic review and meta-analysis

Ischemic stroke remains a major contributor to global mortality and long-term disability, with antiplatelet therapy representing a fundamental strategy for secondary prevention. Cilostazol and clopidogrel are widely utilized antiplatelet agents; however, existing comparative evidence on their safety and efficacy, parti...